natgillin/translations-raw huggingface dataset:
The active substance in Gliolan, 5-aminolevulinic acid, is a ‘sensitiser used in photodynamic therapy’.
Zdravilna učinkovina v zdravilu Gliolan, 5-aminolevulinska kislina, je pripravek, namenjen uporabi pri fotodinamični terapiji.
The active substance in Glustin is pioglitazone.
Zdravilna učinkovina zdravila Glustin je pioglitazon.
The active substance in Glybera, alipogene tiparvovec, is derived from a virus that has been modified so it can carry the lipoprotein lipase gene into the body’s cells.
Zdravilno učinkovino v zdravilu Glybera, alipogentiparvovek, pridobivajo iz virusa, ki ga spremenijo tako, da lahko prenaša gen za lipoproteinsko lipazo v telesne celice.
The active substance in Grastofil, filgrastim, is very similar to a human protein called granulocyte colony stimulating factor (G-CSF).
Zdravilna učinkovina v zdravilu Grastofil, filgrastim, je zelo podobna človeški beljakovini, ki jo imenujemo granulocitne kolonije stimulirajoči faktor (G-CSF).
The active substance in Helixate NexGen, human coagulation factor VIII, is a substance that helps the blood to clot.
Zdravilna učinkovina zdravila Helixate NexGen, humani koagulacijski faktor VIII, je snov, ki pomaga pri strjevanju krvi.
The active substance in Hepsera is adefovir dipivoxil.
Zdravilna učinkovina v zdravilu Hepsera je dipivoksiladefovirat.
The active substance in Hepsera, adefovir dipivoxil, is a ‘prodrug’ that is converted into adefovir in the body.
Zdravilna učinkovina v zdravilu Hepsera, dipivoksiladefovirat, je predzdravilo, ki se v telesu pretvori v adefovir.
The active substance in Hirobriz Breezhaler, indacaterol, is a beta 2 adrenergic receptor agonist.
Zdravilna učinkovina v zdravilu Hirobriz Breezhaler, indakaterol, je agonist adrenergičnih receptorjev beta 2.
The active substance in Hizentra, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Zdravilna učinkovina v zdravilu Hizentra je humani polispecifični imunoglobulin, ki je temeljito prečiščena beljakovina, pripravljena iz človeške plazme (dela krvi).
The active substance in Holoclar is the patient’s own limbal cells, which include cells from the surface of the cornea and limbal stem cells grown in a laboratory.
Zdravilna učinkovina zdravila Holoclar so bolnikove lastne limbusne celice, ki vključujejo celice s površine roženice in limbusne matične celice, vzgojene v laboratoriju.
The active substance in Humalog, insulin lispro, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced, which makes them able to produce insulin lispro.
Zdravilno učinkovino v zdravilu Humalog, insulin lispro, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v bakterijo vstavi gen (DNK), s katerim lahko tvori insulin lispro.
The active substance in Humira, adalimumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a chemical messenger in the body called tumour necrosis factor (TNF).
Zdravilna učinkovina zdravila Humira, adalimumab, je monoklonsko protitelo (vrsta beljakovine), ki je bilo zasnovano tako, da v telesu prepozna kemičnega prenašalca, imenovanega tumorje nekrotizirajoči faktor (TNF), in se veže nanj.
The active substance in Hycamtin, topotecan, is a cancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Zdravilna učinkovina v zdravilu Hycamtin, topotekan, je zdravilo za zdravljenje raka, ki spada v skupino zaviralcev topoizomeraze.
The active substance in Iclusig, ponatinib, belongs to a group of medicines called ‘tyrosine kinase inhibitors’.
Zdravilna učinkovina zdravila Iclusig, ponatinib, spada v skupino zdravil, ki se imenujejo zaviralci tirozin-kinaze.
The active substance in IDELVION is albutrepenonacog alfa (recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)).
Zdravilna učinkovina v zdravilu IDELVION je albutrepenonakog alfa (rekombinantni fuzijski protein, sestavljen iz koagulacijskega faktorja IX, povezanega z albuminom (rIX-FP)).
The active substance in Ifirmasta, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina zdravila Ifirmasta, irbesartan, je antagonist receptorjev angiotenzina II, kar pomeni, da v telesu prepreči delovanje hormona, imenovanega angiotenzin II.
The active substance in Ikervis, ciclosporin, acts on cells of the immune system (the body’s natural defences) that are involved in the processes that cause inflammation.
Zdravilna učinkovina v zdravilu Ikervis, ciklosporin, deluje na celice imunskega sistema (naravnega obrambnega mehanizma telesa), ki sodelujejo pri procesih, ki povzročajo vnetje.
The active substance in Ilaris, canakinumab, is a monoclonal antibody, a type of protein that has been designed to recognise and attach to a specific structure (called an antigen) that is found on certain cells in the body.
Zdravilna učinkovina v zdravilu Ilaris, kanakinumab,je monoklonsko protitelo, tj. vrsta beljakovine, ki je bila zasnovano tako, da prepozna posebno strukturo (imenovano antigen) na določenih celicah v telesu, in se veže nanjo.
The active substance in Imatinib Accord, imatinib, is a protein-tyrosine kinase inhibitor.
Zdravilna učinkovina v zdravilu Imatinib Accord, imatinib, je zaviralec protein-tirozin-kinaze.
The active substance in Imatinib Actavis, imatinib, is a protein-tyrosine-kinase inhibitor.
Zdravilna učinkovina v zdravilu Imatinib Actavis, imatinib, je zaviralec protein-tirozin-kinaze.
The active substance in Imlygic, talimogene laherparepvec, is a type of gene therapy called ‘oncolytic virus’.
Zdravilna učinkovina zdravila Imlygic, talimogen laherparepvek, je vrsta zdravila za gensko zdravljenje, imenovana „onkolitični virus“.
The active substance in Imnovid, pomalidomide, is an immunomodulating agent.
Zdravilna učinkovina zdravila Imnovid, lenalidomid, je imunomodulator.
The active substance in Imrestor 15 mg solution for injection for cattle is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zdravilna učinkovina v zdravilu Imrestor 15 mg raztopina za injiciranje za govedo je dovoljena učinkovina, kot je navedena v tabeli 1 priloge Uredbe Komisije (EU) št.
The active substance in Incruse, umeclidinium bromide, is a muscarinic receptor antagonist.
Zdravilna učinkovina v zdravilu Incruse, umeklidinijev bromid, je antagonist muskarinskih receptorjev.
The active substance in Inflacam is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) 37/2010:
Zdravilna učinkovina zdravila Inflacam in kot je navedena v tabeli 1(dovoljene snovi) priloge Uredbe Komisije (EU) št.37/2010, je dovoljena učinkovina
The active substance in Inhixa, enoxaparin, is one of a group of anticoagulant medicines called ‘low-molecular weight heparins’.
Zdravilna učinkovina v zdravilu Inhixa, enoksaparin, spada v skupino antikoagulacijskih zdravil, imenovanih „nizkomolekularni heparini“.
The active substance in Inlyta, axitinib, works by blocking some enzymes known as tyrosine kinases that are found in ‘vascular endothelial growth factor’ (VEGF) receptors on the surface of cancer cells.
Aksitinib, zdravilna učinkovina v zdravilu Inlyta, deluje tako, da zavira nekatere encime, znane kot tirozinske kinaze, ki so prisotni v receptorjih žilnih endotelijskih rastnih faktorjev (vascular endothelial growth factors – VEGF) na površini rakavih celic.
The active substance in Inovelon, rufinamide, is an anti-epileptic medicine.
Rufinamid, zdravilna učinkovina v zdravilu Inovelon, je zdravilo proti epilepsiji.
The active substance in Instanyl, fentanyl, is an opioid.
Zdravilna učinkovina zdravila Instanyl, fentanil, je opioid.
The active substance in Insulatard, human insulin, is produced by a method known as ‘recombinant technology’: the insulin is made by yeast cells into which a gene (DNA) has been introduced, which makes them able to produce insulin.
Zdravilna učinkovina v zdravilu Insulatard, humani insulin, se proizvaja z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v celice kvasovk vstavi gen (DNK), ki jim daje sposobnost tvorjenja insulina.
The active substance in Insulin Human Winthrop, insulin human, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin.
Zdravilno učinkovino v zdravilu Insulin Human Winthrop, humani insulin, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri bakterija prejme gen (DNK), s katerim lahko tvori insulin.
The active substance in Insuman, human insulin, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced that makes the bacteria able to produce insulin.
Zdravilna učinkovina zdravila Insuman, humani insulin, se proizvaja z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v bakterije vstavi gen (DNK), s katerim lahko tvorijo insulin.
The active substance in Intelence, etravirine, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Zdravilna učinkovina zdravila Intelence, etravirin, je nenukleozidni zaviralec reverzne transkriptaze (NNRTI).
The active substance in IntronA, interferon alfa-2b, belongs to the group ‘interferons’.
Zdravilna učinkovina zdravila IntronA, interferon alfa-2b, spada v skupino interferonov.
The active substance in Invanz, ertapenem, is an antibiotic that belongs to the group known as ‘carbapenems’.
Zdravilna učinkovina zdravila Invanz, ertapenem, je antibiotik iz skupine „karbapenemov“.
The active substance in Invega, paliperidone, is an antipsychotic medicine.
Zdravilna učinkovina zdravila Invega, paliperidon, je antipsihotično zdravilo.
The active substance in Invirase, saquinavir, is a ‘protease inhibitor’.
Zdravilna učinkovina zdravila Invirase, sakvinavir, je zaviralec proteaze.
The active substance in Ipreziv, azilsartan medoxomil, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Ipreziv, medoksomilazilsartanat, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Irbesartan BMS, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Irbesartan BMS, irbesartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Irbesartan Teva, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Irbesartan Teva, irbesartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Irbesartan Zentiva, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Irbesartan Zentiva, irbesartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Isentress, raltegravir, is an integrase inhibitor.
Zdravilna učinkovina zdravila Isentress, raltegravir, je zaviralec integraze.
The active substance in Ivabradine Anpharm, ivabradine, works by blocking the ‘If currents’ in the sinus node, the natural ‘pacemaker’ that controls the heart’s contractions and regulates the heart rate.
Zdravilna učinkovina zdravila Ivabradine Anpharm, ivabradin, deluje tako, da zavira „tokove If“ v sinusnem vozlu, tj. naravnem spodbujevalniku srca, ki nadzoruje krčenje srca in uravnava srčni utrip.
The active substance in Ivemend, fosaprepitant, is a ‘prodrug’ of aprepitant.
Zdravilna učinkovina v zdravilu Ivemend, fosaprepitant, je „predzdravilo“ aprepitanta.
The active substance in Izba, travoprost, is a prostaglandin analogue (a man-made version of a prostaglandin, substances naturally found in the body).
Zdravilna učinkovina zdravila Izba, travoprost, je analog prostaglandina (kopije v človeškem telesu naravno obstoječe spojine, prostaglandina, ki jo izdela človek).
The active substance in Jardiance, empagliflozin, works by blocking a protein in the kidneys called sodium-glucose co-transporter 2 (SGLT2).
Zdravilo Jardiance vsebuje zdravilno učinkovino empagliflozin, ki deluje tako, da v ledvicah zavira beljakovino, imenovano natrijev glukozni prenašalec 2 (SGLT2, sodium-glucose co-transporter 2).
The active substance in Jevtana, cabazitaxel, belongs to the group of cancer medicines known as ‘taxanes’.
Zdravilna učinkovina zdravila Jevtana, cabazitaksel, spada v skupino zdravil proti raku, ki so znana kot taksani.
The active substance in Jinarc, tolvaptan, is a vasopressin-2-receptor antagonist: it works by blocking receptors in the kidneys to which the hormone vasopressin attaches.
Zdravilna učinkovina v zdravilu Jinarc, tolvaptan, je antagonist vazopresinskih receptorjev-2: deluje tako, da zavira receptorje v ledvicah, na katere se veže hormon vazopresin.
The active substance in Kalydeco, ivacaftor, increases the activity of the defective channels in patients with the mutations G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R or R117H.
Zdravilna učinkovina zdravila Kalydeco, ivakaftor, poveča delovanje okvarjenih kanalčkov pri bolnikih, ki imajo mutacije G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R ali R117H.
The active substance in Karvea, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Karvea, irbesartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Ketek, telithromycin, is an antibiotic belonging to the class ‘ketolides’.
Zdravilna učinkovina zdravila Ketek, telitromicin, je antibiotik iz skupine „ketolidov“.
The active substance in Keytruda, pembrolizumab, is a monoclonal antibody.
Zdravilna učinkovina v zdravilu Keytruda, pembrolizumab, je monoklonsko protitelo.
The active substance in Kineret, anakinra, is an immunosuppressive medicine (a medicine that reduces the activity of the immune system).
Zdravilna učinkovina zdravila Kineret, anakinra, je imunosupresivno zdravilo (zdravilo za zaviranje delovanja imunskega sistema).
The active substance in Kinzalmono, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Kinzalmono, telmisartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Kiovig, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Zdravilna učinkovina zdravila Kiovig, humani normalni imunoglobulin, je močno prečiščena beljakovina, pridobljena iz človeške plazme (dela krvi).
The active substance in Kisplyx, lenvatinib, is a ‘tyrosine-kinase inhibitor’.
Zdravilna učinkovina v zdravilu Kisplyx, lenvatinib, je zaviralec tirozin kinaze.
The active substance in Kogenate Bayer, human coagulation factor VIII, is a substance that helps the blood to clot.
Zdravilna učinkovina zdravila Kogenate Bayer, humani koagulacijski faktor VIII, je snov, ki pomaga pri strjevanju krvi.
The active substance in Lantus, insulin glargine, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glargine.
Zdravilno učinkovino v zdravilu Lantus, insulin glargin, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri bakterija prejme gen (DNK), s katerim lahko tvori insulin glargin.
The active substance in Lartruvo, olaratumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a protein called ‘platelet-derived growth factor receptor alpha’ (PDGFRα).
Zdravilna učinkovina v zdravilu Lartruvo, olaratumab, je monoklonsko protitelo (vrsta beljakovine), zasnovano za prepoznavo in vezavo na beljakovino, imenovano receptor alfa za trombocitni rastni dejavnik (PDGFRα).
The active substance in Leflunomide Winthrop, leflunomide, is an immunosuppressant.
Zdravilna učinkovina zdravila Leflunomide Winthrop, leflunomid, je zdravilo za selektivno zaviranje imunske odzivnosti.
The active substance in Lenvima, lenvatinib, is a ‘tyrosine-kinase inhibitor’.
Zdravilna učinkovina v zdravilu Lenvima, lenvatinib, je zaviralec tirozin-kinaze.
The active substance in Liprolog, insulin lispro, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced, which makes them able to produce insulin lispro.
Zdravilno učinkovino v zdravilu Liprolog, insulin lispro, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v bakterijo vstavi gen (DNK), s katerim lahko tvori insulin lispro.
The active substance in Lixiana, edoxaban, is a ‘factor Xa inhibitor’.
Zdravilna učinkovina v zdravilu Lixiana, edoksaban, je zaviralec faktorja Xa.
The active substance in Lonquex, lipegfilgrastim, is similar to granulocyte colony stimulating factor (G‑CSF), a naturally occurring protein in the body that promotes the production of white blood cells including neutrophils in the bone marrow.
Zdravilna učinkovina v zdravilu Lonquex, lipegfilgrastim, je podobna granulocitne kolonije stimulirajočemu faktorju (G-CSF), tj. naravni beljakovini, ki nastaja v telesu in spodbuja tvorjenje belih krvnih celic, vključno z nevtrofilci, v kostnem mozgu.
The active substance in Loxicom is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010.
Meloksikam v zdravilu Loxicom 50 mg/g peroralna pasta za konjeje dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.37/2010:
The active substance in Lucentis, ranibizumab, is a small piece of a monoclonal antibody.
Zdravilna učinkovina zdravila Lucentis, ranibizumab, je delec monoklonskega protitelesa.
The active substance in Lumark, lutetium (177Lu) chloride, is a radioactive compound that mainly emits a type of radiation known as beta radiation, with small amounts of gamma radiation.
Zdravilna učinkovina v zdravilu Lumark, lutecijev (177Lu) klorid, je radioaktivna spojina, ki v glavnem oddaja vrsto sevanja, ki ga imenujemo beta sevanje, skupaj z majhnimi količinami gama sevanja.
The active substance in Lynparza, olaparib, blocks the action of enzymes called human poly (ADP ribose) polymerase (PARP), which help to repair damaged DNA in cells (both in normal and in cancer cells) during cell division.
Zdravilna učinkovina zdravila Lynparza, olaparib, zavira delovanje človeških encimov, imenovanih poli(ADP-riboza)polimeraze (PARP), ki pomagajo popraviti poškodovano DNK v celicah (tako v normalnih kot v rakavih) med delitvijo celic.
The active substance in Lyrica, pregabalin, is similar in structure to the body’s own ‘neurotransmitter’ gamma-amino butyric acid (GABA), but has very different biological effects.
Zdravilna učinkovina v zdravilu Lyrica, pregabalin, ima podobno zgradbo kot telesu lastni „živčni prenašalec“ gama-aminomaslena kislina (GABA), vendar ima bistveno drugačne biološke učinke.
The active substance in Lyxumia, lixisenatide, is a ‘GLP-1 receptor agonist’.
Zdravilna učinkovina v zdravilu Lyxumia, liksisenatid, je agonist receptorjev glukagonu podobnega peptida 1 (GLP-1).
The active substance in MabThera, rituximab, is a monoclonal antibody designed to recognise and attach to a protein called CD20 present on the surface of B-lymphocytes.
Zdravilna učinkovina zdravila MabThera, rituksimab, je monoklonsko protitelo, zasnovano tako, da prepozna beljakovino, imenovano CD20, ki je prisotna na površini limfocitov B, in se veže nanjo.
The active substance in MACI consists of the patient’s own cartilage cells, which are implanted into the cartilage defect in the knee.
Zdravilna učinkovina zdravila MACI je sestavljena iz bolnikovih lastnih hrustančnih celic, ki se vsadijo v okvarjen hrustanec v kolenu.
The active substance in Macugen, pegaptanib, is an ‘aptamer’.
Zdravilna učinkovina zdravila Macugen, pegaptanib, je aptamer.
The active substance in Mekinist, trametinib, works by blocking MEK directly and by preventing its activation by BRAF thereby slowing down the growth and spread of the cancer.
Zdravilna učinkovina v zdravilu Mekinist, trametinib, deluje tako, da neposredno zavira beljakovino MEK, beljakovini BRAF pa prepreči, da bi jo aktivirala, s čimer upočasni rast in širjenje raka.
The active substance in Melovem is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zdravilna učinkovina v Melovem je dovoljena učinkovina, kot je navedena v tabeli 1(dovoljene snovi) priloge Uredbe Komisije (EU) št.37/2010:
The active substance in Meloxidolor is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zdravilna učinkovina v zdravilu Meloxidolor je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
The active substance in Meloxidyl is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zdravilna učinkovina v zdravilu Meloxidyl je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
The active substance in Metacam is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Zdravilna učinkovina v zdravilu Metacam je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
The active substance in Metalyse, tenecteplase, is a modified copy of the human enzyme ‘tissue plasminogen activator’, which the body uses to break down clots.
Zdravilna učinkovina v zdravilu Metalyse, tenekteplaza, je spremenjena kopija človeškega encima, in sicer tkivnega plazminogenskega aktivatorja, ki ga telo uporablja za razgradnjo krvnih strdkov.
The active substance in Micardis, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Micardis, telmisartan, je „antagonist receptorjev angiotenzina II“, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Mimpara, cinacalcet, is a calcimimetic agent.
Zdravilna učinkovina v zdravilu Mimpara, cinakalcet, je kalcimimetično sredstvo.
The active substance in Mircera is made up of epoetin beta attached to a chemical called methoxy- polyethylene glycol.
Zdravilna učinkovina zdravila Mircera je sestavljena iz epoetina beta, vezanega na kemijsko snov, imenovano metoksipolietilenglikol.
The active substance in Mixtard, human insulin, is produced by a method known as ‘recombinant technology’: the insulin is made by a yeast cells into which a gene (DNA) has been introduced, which makes them able to produce insulin.
Zdravilna učinkovina v zdravilu Mixtard, humani insulin, se proizvaja z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v celice kvasovk vstavi gen (DNK), ki jim daje sposobnost tvorjenja insulina.
The active substance in Mozobil, plerixafor, works by blocking the activity of a protein called the ‘CXCR4 chemokine receptor’.
Zdravilna učinkovina zdravila Mozobil pleriksafor deluje z zaviranjem dejavnosti beljakovine, imenovane „kemokinski receptor CXCR4“.
The active substance in Multaq, dronedarone, is an anti-arrhythmic medicine.
Zdravilna učinkovina zdravila Multaq, dronedaron, je zdravilo proti aritmiji.